Skip to main content
OpenTrials
Completed

NCT Number: NCT01344122

Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE)

The goal of this study is to see whether or not a strategic planning process is able to introduce and sustain improvements in the working relationship between probation/parole departments and community-based addiction treatment agencies that provide medication assisted therapy (MAT) for individuals with opioid or alcohol dependence. In addition, this study seeks to improve probation/parole agency personnel's knowledge and perceptions about MAT, and increase the number of appropriate referrals to community treatment agencies that provide MAT. There are three phases to this study. Phase 1 includes a pilot study to determine the quality and availability of client level records and the collection of baseline data (the pilot study protocol was previously submitted to TMH IRB). Phase 2 will consist of a Knowledge, Perceptions and Information (KPI) intervention during which probation/parole agencies will undergo training to increase knowledge about the effectiveness of MAT, and complete a post training assessment to evaluate the effectiveness of the KPI intervention. During Phase 3, probation/parole agencies will be randomly assigned to a 12-month Organizational Linkage Intervention (OLI) condition or to control (no further intervention). Agencies assigned to the OLI will establish a Pharmacotherapy Exchange Council (PEC) that consists of staff from both the probation/parole and community treatment agencies. The PEC will undergo a strategic planning process to increase the availability of MAT for opiate and/or alcohol dependent individuals who are on probation/parole.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Probation/parole or community treatment agency staff.

Treatment and study plan

KPI training only

Other

See comparison arm description.

KPI plus OLI

Other

See experimental arm description.

Primary outcomes

  1. Opinions About MAT

    Time frame: 6-month follow-up

    Measures knowledge, perceptions, and intentions regarding the use of pharmacotherapy for the treatment of opioid and alcohol dependence. Will be assessed at baseline, post-training, post intervention, and 6-month follow-up.

Secondary outcomes

  1. Interorganizational Relationships

    Time frame: 6-month follow-up

    Will be assessed at baseline, and post intervention (6-month follow-up).

  2. Referrals to Medication Assisted Treatment (MAT)

    Time frame: 6-Month Follow-up

    Estimated numbers of alcohol- and opiate-dependent offenders on Probation/Parole

Sponsors and collaborators

Lead sponsor

Rhode Island Hospital

Other

Collaborators

  • Arizona State University
  • Friends Research Institute, Inc.
  • National Development and Research Institutes, Inc.
  • National Institute on Drug Abuse (NIDA)
  • Temple University
  • Texas Christian University
  • University of California, Los Angeles
  • University of Connecticut
  • University of Delaware
  • University of Kentucky
  • University of Puerto Rico

Registry information

Acronym: MATICCE

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Apr 28, 2011
Registry last updated
Oct 30, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.